Combatting PDAC with two tumor-targeting small RNAs
Combatting PDAC with two tumor-targeting small RNAs |
|
https://doi.org/10.18632/oncotarget.27245
Andrea L. Kasinski
|
| 5892-5893 |
Malignant ascites: a source of therapeutic protein against ovarian cancer?
Malignant ascites: a source of therapeutic protein against ovarian cancer? |
|
https://doi.org/10.18632/oncotarget.27185
Pascale Ribaux,
Aurore Britan,
Gabriele Thumann,
Florence Delie,
Patrick Petignat,
and Marie Cohen
|
| 5894-5905 |
Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer
Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer |
|
https://doi.org/10.18632/oncotarget.27187
Yosuke Ooizumi,
Hiroshi Katoh,
Mitsuo Yokota,
Masahiko Watanabe,
and Keishi Yamashita
|
| 5906-5918 |
Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma
Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma |
|
https://doi.org/10.18632/oncotarget.27194
Shatha Albattal,
Meshael Alswailem,
Yosra Moria,
Hindi Al-Hindi,
Majed Dasouki,
Mohamed Abouelhoda,
Hala Aba Alkhail,
Entissar Alsuhaibani,
and Ali S. Alzahrani
|
| 5919-5931 |
The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer
The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.27219
Shiho Fukui,
Kazunori Nagasaka,
Yuko Miyagawa,
Ryoko Kikuchi-Koike,
Yoshiko Kawata,
Ranka Kanda,
Takayuki Ichinose,
Takeru Sugihara,
Haruko Hiraike,
Osamu Wada-Hiraike,
Yuko Sasajima,
and Takuya Ayabe
|
| 5932-5948 |
Germline mutations in cancer-predisposition genes in patients with biliary tract cancer
Germline mutations in cancer-predisposition genes in patients with biliary tract cancer |
|
https://doi.org/10.18632/oncotarget.27224
Takeshi Terashima,
Kumiko Umemoto,
Hideaki Takahashi,
Hiroko Hosoi,
Erina Takai,
Shunsuke Kondo,
Yasunari Sakamoto,
Shuichi Mitsunaga,
Izumi Ohno,
Yusuke Hashimoto,
Mitsuhito Sasaki,
Masafumi Ikeda,
Kazuaki Shimada,
Shuichi Kaneko,
Shinichi Yachida,
Kokichi Sugano,
Takuji Okusaka,
and Chigusa Morizane
|
| 5949-5957 |
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27234
Bahir H. Chamseddin,
Eunice E. Lee,
Jiwoong Kim,
Xiaowei Zhan,
Rong Yang,
Kathleen M. Murphy,
Cheryl Lewis,
Gregory A. Hosler,
Suntrea T. Hammer,
and Richard C. Wang
|
| 5958-5969 |
ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer
ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.27235
Nikhil Gupta,
Jung Eun Park,
Wilford Tse,
Jee Keem Low,
Oi Lian Kon,
Neil McCarthy,
and Siu Kwan Sze
|
| 5970-5982 |
DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells
DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells |
|
https://doi.org/10.18632/oncotarget.27236
Francina J. Dijk,
Miriam van Dijk,
Bram Dorresteijn,
and Klaske van Norren
|
| 5983-5992 |
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma |
|
https://doi.org/10.18632/oncotarget.27243
Qiang Qiu,
Mengyuan Li,
Linyu Yang,
Minghai Tang,
Li Zheng,
Fang Wang,
Huandi Qiu,
Cailing Liang,
Ning Li,
Dongni Yi,
Yuyao Yi,
Cong Pan,
Shengyong Yang,
Lijuan Chen,
and Yiguo Hu
|
| 5993-6005 |
T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells
T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells |
|
https://doi.org/10.18632/oncotarget.10298
Prachi Namjoshi,
Lori Showalter,
Brian J. Czerniecki,
and Gary K. Koski
|
| 6006-6020 |
Splicing regulatory factors in breast cancer hallmarks and disease progression
Splicing regulatory factors in breast cancer hallmarks and disease progression |
|
https://doi.org/10.18632/oncotarget.27215
Esmee Koedoot,
Liesanne Wolters,
Bob van de Water,
and Sylvia E. Le Dévédec
|
| 6021-6037 |
Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report |
|
https://doi.org/10.18632/oncotarget.27203
Mayank Rao,
Meenakshi Bhattacharjee,
Scott Shepard,
and Sigmund Hsu
|
| 6038-6042 |
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening |
|
https://doi.org/10.18632/oncotarget.27256
Stefano Sestini,
Mattia Boeri,
Alfonso Marchiano,
Giuseppe Pelosi,
Carlotta Galeone,
Carla Verri,
Paola Suatoni,
Nicola Sverzellati,
Carlo La Vecchia,
Gabriella Sozzi,
and Ugo Pastorino
|
| 6043-6043 |
Correction: Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis
Correction: Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis |
|
https://doi.org/10.18632/oncotarget.27257
Haiyan Tan,
Chun Zeng,
Junbo Xie,
Norah J. Alghamdi,
Ya Song,
Hongbing Zhang,
Aimin Zhou,
and Di Jin
|
| 6044-6044 |
Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation
Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation |
|
https://doi.org/10.18632/oncotarget.27258
Aaditya Khatri,
Jing Jin Gu,
Courtney M. McKernan,
Xia Xu,
and Ann Marie Pendergast
|
| 6045-6046 |
